 | | PRD_000767 | | Name: | CYCLOSPORIN A, 7 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002527 | | Name: | Intermediate for maxamycins synthesis | | Formula: | C84 H114 Cl2 N8 O17 S Si2 | | Definition date: | 2023-07-05 | | Last modified: | 2023-07-05 |
|
 | | PRD_002431 | | Name: | Cyclic tetraadenosine monophosphate (cA4) | | Formula: | C40 H48 N20 O24 P4 | | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-03 |
|
 | | PRD_001065 | | Name: | teicoplanin | | Formula: | C88 H97 Cl2 N9 O34 | | Definition date: | 2013-05-29 | | Last modified: | 2023-06-11 |
|
 | | PRD_002346 | | Name: | Inhibitor ARC-3126 | | Formula: | C58 H108 Br N31 O9 S | | Definition date: | 2021-08-04 | | Last modified: | 2023-06-11 |
|
 | | PRD_002353 | | Name: | Blood group B type 1 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Definition date: | 2022-03-02 | | Last modified: | 2023-06-11 |
|
 | | PRD_002516 | | Name: | cyclic peptide inhibitor 1 | | Formula: | C111 H132 N23 O30 S | | Definition date: | 2023-03-22 | | Last modified: | 2023-03-22 |
|
 | | PRD_002424 | | Name: | Darobactin 22 | | Formula: | C53 H67 N15 O11 | | Definition date: | 2023-01-11 | | Last modified: | 2023-01-11 |
|
 | | PRD_002430 | | Name: | Darobactin 9 | | Formula: | C49 H57 N12 O12 | | Definition date: | 2023-01-11 | | Last modified: | 2023-01-11 |
|
 | | PRD_002492 | | Name: | Sa-D3 | | Formula: | C87 H110 N18 O24 S | | Definition date: | 2022-08-10 | | Last modified: | 2022-08-10 |
|
 | | PRD_002384 | | Formula: | C58 H95 N15 O15 | | Definition date: | 2022-08-03 | | Last modified: | 2022-08-03 |
|
 | | PRD_000468 | | Name: | Allosamidin | | Formula: | C25 H42 N4 O14 | | Definition date: | 2015-07-18 | | Last modified: | 2022-03-03 |
|
 | | PRD_000041 | | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R,6S)-3,5-DIAM
INO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(
HYDROXYMETHYL)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | | Formula: | C28 H57 N7 O14 | | Definition date: | 2017-07-12 | | Last modified: | 2022-03-02 |
|
 | | PRD_000042 | | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4
,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDI
N-3-YLMETHYLAMINO)ETHOXY)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | | Formula: | C31 H61 N7 O14 | | Definition date: | 2017-07-12 | | Last modified: | 2022-03-02 |
|
 | | PRD_002479 | | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | | Formula: | C34 H48 F3 N6 O14 P | | Definition date: | 2022-03-02 | | Last modified: | 2022-03-02 |
|
 | | PRD_002383 | | Name: | des4.3.1 | | Formula: | C44 H74 N12 O11 S | | Definition date: | 2021-04-28 | | Last modified: | 2021-04-28 |
|
 | | PRD_002362 | | Name: | GsIN-1 peptide | | Formula: | C79 H106 N16 O21 S | | Definition date: | 2021-04-21 | | Last modified: | 2021-04-21 |
|
 | | PRD_002267 | | Name: | D-Arg4,Leu10-Teixobactin | | Formula: | C59 H101 N14 O14 | | Definition date: | 2020-08-19 | | Last modified: | 2020-08-19 |
|
 | | PRD_002272 | | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | | Formula: | C25 H44 N14 O7 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_002295 | | Formula: | C89 H131 N23 O25 S3 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
 | | PRD_900060 | | Name: | ACARBOSE DERIVED HEXASACCHARIDE | | Formula: | C36 H63 N O29 | | Description: | oligosaccharide with N-glycosidic bond between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-08-05 |
|
 | | PRD_900106 | | Name: | 6-S-alpha-D-mannopyranosyl-6-thio-alpha-D-mannopyranose | | Formula: | C12 H22 O10 S | | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-08-05 |
|
 | | PRD_900010 | | Name: | MALTOTETRAOSE | | Formula: | C24 H42 O21 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900011 | | Name: | beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranose | | Formula: | C24 H42 O21 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900012 | | Name: | BETA-CYCLODEXTRIN | | Formula: | C42 H70 O35 | | Description: | cyclic oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
